Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

COVID-19 vaccines do not increase the risk of alopecia areata.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Pertussis toxin may contribute to hair loss in alopecia areata.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Recognizing rare hair loss patterns in young females can improve understanding and treatment.

Topical tofacitinib is effective and safe for treating alopecia areata.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Minoxidil with triamcinolone acetonide is more effective for mild alopecia areata when injected with microneedles than when applied topically.

Children with alopecia areata in Singapore generally have a good quality of life.

Baricitinib improved nail condition and hair regrowth in a patient with alopecia and nail abnormalities.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Alopecia areata costs individuals about 3% of their income, with women, Asians, those with lower income, and more severe symptoms spending more.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.